Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania. Show more
Location: 3222 Phoenixville Pike, Malvern, PA, 19355, United States | Website: https://neurostar.com | Industry: Medical Devices | Sector: Healthcare
Market Cap
236M
52 Wk Range
$0.52 - $5.92
Previous Close
$3.57
Open
$3.59
Volume
796,313
Day Range
$3.54 - $3.89
Enterprise Value
296.1M
Cash
20.22M
Avg Qtr Burn
-8.994M
Insider Ownership
9.17%
Institutional Own.
62.81%
Qtr Updated
03/31/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|